Associate Professor Iaroslav Lutay
Institut of Cardiology, Kyiv (Ukraine)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
No-reflow, acute heart failure and ventricular fibrillation are more common in STEMI patients in wartime conditions.
Event: ESC Congress 2023
Topic: ST-Elevation Myocardial Infarction (STEMI)
Session: Epidemiology in acute coronary syndromes (1)
Early intensive lipid-lowering therapy prevents development of no-reflow phenomenon and reduces the incidence of post MI LV remodeling
Event: ESC Congress 2017
Topic: Infarction acute phase STEMI
Session: STEMI / NSTEMI
Positive effects of intravenous 5-lipoxygenase inhibitor quercetin in acute ST elevation myocardial infarction: intermediate results of ongoing randomized open blinded multicenter study
Event: Acute Cardiovascular Care 2016
Topic: ST-elevation myocardial infarction - ACS
Session: Acute coronary syndrome - ST-elevation myocardial infarction
Low dose ezetimibe / atorvastatin combination in acute ST elevation myocardial infarction
Event: Acute Cardiovascular Care 2016
Topic: ST-elevation myocardial infarction - ACS
Session: Acute coronary syndrome - ST-elevation myocardial infarction
Urapidil is more effective than nitroglycerin in maintaining renal blood flow in patients with hypertensive urgencies.
Event: ESC Congress 2016
Topic: Treatment of hypertension
Session: Hypertension in special conditions
Effects of intravenous 5-lipoxygenase inhibitor quercetin on endothelial function, systemic inflammation and oxidative stress in acute ST elevation myocardial infarction.
Event: ESC Congress 2016
Topic: Adjunctive medical therapy
Session: Adjunctive medical therapy in coronary artery disease
Myeloperoxidase concentration is associated with endothelial dysfunction and can be decreased by lipoxygenase inhibitor Quercetin in acute phase of STEMI.
Event: ESC Congress 2016
Topic: Inflammation and microcirculation
Session: Inflammation and immunity
ESC 365 is supported by
